Product Code: GVR-3-68038-880-0
Lateral Flow Assays Market Growth & Trends:
The global lateral flow assays market size is expected to reach USD 13.59 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 3.05% from 2022 to 2030. Major factors driving the growth include the rising prevalence of infectious diseases, growing government initiatives to curb infectious and chronic diseases, rise in demand for point-of-care testing, and increasing strategic mergers & acquisitions among others.
Lateral flow assays were developed about half a century ago and have facilitated several diagnostic and testing applications in domains such as healthcare, food & beverage testing, and environmental testing. Similarly, lateral flow assay applications in point-of-care diagnostics are growing and are propelling significant advancements in research for the development of products that evaluate body fluids, such as urine and saliva.
The use of these devices promotes self-testing, reduces the need for laboratory testing, and eliminates the need for trained laboratory personnel. Although there have been several technological advancements in laboratory testing in the recent past, several emerging economies still face challenges regarding timely medical intervention. This represents a major factor that is driving the adoption of dipsticks or lateral flow assays for facilitating timely diagnosis and treatment.
Due to the increasing utility of lateral flow assays for home use and self-testing, several at-home tests were launched after the pandemic began. For instance, tests such as Abbott's BinaxNOW COVID-19 Antigen Self-Test, Access Bio's CareStart COVID-19 Antigen Home Test, Becton, Dickinson and Company's BD Veritor At-Home COVID-19 Test, and Ellume's COVID-19 Home Test are commercially available.
Government initiatives supporting the use of such tests are expected to enhance the penetration of lateral flow assays and can aid in driving the lateral flow assays market growth. For instance, the Biden-Harris administration has incentivized health plans and insurers for installing a network of locations across the country for providing at-home, over-the-counter COVID-19 tests for free to people with private health coverage.
Continuous strategic initiatives undertaken by leading and emerging players to develop and launch advanced products are anticipated to significantly support market growth. For instance, in November 2021, IUL SA launched the iPeak Europium, a new lateral flow reader used to scan fluorescence-labeled lateral flow tests. Similarly, in March 2021, the company introduced its new lateral flow reader, iPeak+.
Additionally, in January 2021, Sensyne Health, based in the U.K., introduced an innovative smartphone app-MagnifEye-that employs deep machine learning AI to automate the interpretation of lateral flow diagnostic tests. A rise in mergers and collaborations by market players is anticipated to facilitate access to novel lateral flow technologies.
For instance, in February 2022, U.S.-based BD (Becton, Dickinson and Company) and Scanwell Health collaborated to create an at-home rapid test for SARS-CoV-2 using a BD lateral flow antigen test and the Scanwell Health mobile app. The collaboration aims to provide an efficient and scalable rapid antigen home testing solution.
The use of lateral flow devices also eliminates the need to wait for deciphering test results as well as aids in the optimization of timely treatment decisions, improves the efficacy of care provided, and significantly reduces diagnosis costs, especially in areas with resource-constrained settings and insufficient laboratory infrastructure. The rising trend of decentralized testing has been crucial in increasing the adoption of lateral flow devices globally.
The role of these devices has also been observed in controlling major infectious diseases such as malaria and influenza. According to WHO, rapid diagnostic tests are used in diagnosis by healthcare professionals distant from microscopy services; remote diagnosis by professionals in malaria54-endemic countries; and outbreak investigation & survey of parasite prevalence. Thus, various benefits offered by lateral flow devices are among the key factors responsible for increasing the adoption of lateral flow assays globally.
On the other hand, with the advent of advanced technologies, such as PCR and molecular diagnostics, the demand for lateral flow assays may be witnessing sluggish growth to a certain extent. Although lateral flow assays have high specificity and sensitivity, PCR and other molecular diagnostic technologies have emerged to be more sensitive.
Lateral Flow Assays Market Report Highlights:
- Kits & reagents dominated the market in 2021. These products offer versatility for use in pharmaceuticals, animal health, environmental testing, feed & food testing, and crop & plant testing
- The launch of new self-testing and at-home kits by major players is anticipated to boost market growth during the forecast period. For instance, in July 2021, Abbott Laboratories launched its Panbio COVID-19 Antigen Self-Test in India, which was followed by Roche Diagnostics India's launch of its COVID-19 At-Home Test in January 2022
- Clinical testing held the majority share of the application segment in 2021. Lateral flow assays are used in clinical testing by multiple diagnostic facilities due to ease of use & portability. These tests offer results with a reduced turnaround time as compared to other laboratory tests. In addition, as oral fluid-based testing is gradually developing, the use of lateral flow assays is becoming convenient because of the noninvasive nature of collecting specimens
- Sandwich assays held the largest market share in 2021, owing to their affordability, accuracy, and ease of use. These assays can also be performed in low-resource healthcare settings without the need for prior training. As a result, sandwich assays are widely used, which drives the growth
- Lateral flow immunoassays dominated the test type segment in 2021. These assays can be used for the detection of antigens or antibodies in clinical samples and offer an effective diagnostic option that conforms with the WHO ASSURED criteria for diagnostics. With increasing requirements for point-of-care testing alternatives in recent years, the demand for such assays is projected to grow over the forecast period
- The hospitals & clinics segment held the largest revenue share in 2021. The increasing need for hospitals with enhanced diagnostic services and rising global healthcare expenditure are anticipated to fuel market growth
- Various infectious diseases, such as influenza, HIV, and hepatitis, are easily transmitted in hospitals, often causing outbreaks. To reduce or even eliminate such occurrences, hospitals have to comply with specific guidelines to ensure adequate patient quarantine measures, the safety of healthcare workers, and proper sanitization
- North America held the dominant revenue share owing to an increase in the incidence of infectious diseases such as influenza. For instance, as per the U.S. CDC estimates, between 2010 and 2020, there have been around 9 million to 41 million influenza infection cases, leading to about 140,000 to 710,000 hospitalizations and 12,000 to 52,000 deaths annually in the U.S.
- Asia Pacific is expected to grow at the fastest CAGR from 2022 to 2030 owing to increasing collaborations among market entrants and a rise in product approval for various infectious disease tests is anticipated to boost the growth. For instance, in February 2020, Shenzen Bioeasy Biotechnology announced that the company received CE marking for its COVID-19 LFA immunoassay kits
Table of Contents
Chapter 1 Methodology and Scope
- 1.1 Market Segmentation
- 1.2 Market Scope & Definition
- 1.3 Research Methodology
- 1.4 Information Procurement
- 1.4.1 Purchased Database
- 1.4.2 Gvr's Internal Database
- 1.4.3 Secondary Sources
- 1.4.3.1 Secondary Data Sources:
- 1.4.4 Primary Research
- 1.4.4.1 Primary Sources:
- 1.4.4.1.1 Data for primary interviews in North America
- 1.4.4.1.2 Data for Primary Interviews in Europe
- 1.4.4.1.3 Data for Primary Interviews in Asia Pacific
- 1.4.4.1.4 Data for Primary Interviews in Latin America
- 1.4.4.1.5 Data for Primary Interviews in Middle East & Africa
- 1.5 Information or Data Analysis
- 1.5.1 Data Analysis Models
- 1.6 Market Formulation & Validation
- 1.7 Market Model
- 1.8 Objectives
- 1.8.1 Objective 1:
- 1.8.2 Objective 2:
- 1.9 List of Abbreviations
Chapter 2 Executive Summary
- 2.1 Market Snapshot
- 2.2 Market Outlook
Chapter 3 Lateral Flow Assay Market Variables, Trends, & Scope
- 3.1 Market Lineage Outlook
- 3.1.1 Parent Market Outlook
- 3.2 Penetration And Growth Prospect Mapping
- 3.2.1 Key Opportunities Prioritized, By Product
- 3.2.2 Key Opportunities Prioritized, By Application
- 3.2.3 Key Opportunities Prioritized, By Technique
- 3.2.4 Key Opportunities Prioritized, By End-Use
- 3.3 User Perspective Analysis
- 3.3.1 Consumer Behavior Analysis
- 3.4 Incidence Data, Infectious Diseases
- 3.4.1 COVID-19
- 3.4.1.1 U.S. COVID-19 total cases
- 3.4.1.2 Europe COVID-19 total cases
- 3.4.1.3 India COVID-19 total cases
- 3.4.2 Yellow Fever
- 3.4.3 Dengue
- 3.4.4 Zika
- 3.4.5 West Nile Virus
- 3.4.6 Influenza
- 3.5 Market Dynamics
- 3.5.1 Market Driver Analysis
- 3.5.1.1 Rising prevalence of chronic and infectious diseases
- 3.5.1.2 Growing Demand for Point-Of-Care Testing
- 3.5.1.3 Increase in Usage of Home-Based Lateral Flow Assay Devices
- 3.5.2 Market Restraint Analysis
- 3.5.2.1 Advent Of Advanced Techniques Such As Pcr And Molecular Diagnostics
- 3.5.2.2 Frequent Product Recalls
- 3.5.3 Market Challenge Analysis
- 3.5.3.1 Environmental Problems Caused Due To The Use Of Lateral Flow Assay Devices
- 3.6 Lateral Flow Assays: Market Analysis Tools
- 3.6.1 Industry Analysis - Porter's
- 3.6.2 Lateral Flow Assay Market - Swot Analysis, By Factor (Political & Legal, Economic And Technological)
- 3.7 COVID-19 Impact Analysis
Chapter 4 Lateral Flow Assay Market: Product Estimates and Trend Analysis
- 4.1 Segment Dashboard
- 4.2 Lateral flow assay market: Product Outlook, 2021 & 2030
- 4.3 Global Lateral Flow Assay Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030
- 4.3.1 Kits & Reagents
- 4.3.1.1 Kits & Reagents Market, Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 4.3.2 Lateral Flow Readers
- 4.3.2.1 Lateral Flow Readers Market, market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.3.2.2 Benchtop Lateral Flow Readers
- 4.3.2.2.1 Benchtop Lateral Flow Readers Market, market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.3.2.3 Digital/Mobile Lateral Flow Readers
- 4.3.2.3.1 Digital/Mobile Lateral Flow Readers Market, market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 5 Lateral Flow Assay Market: Application Estimates and Trend Analysis
- 5.1 Segment Dashboard
- 5.2 Lateral Flow Assay Market: Application Outlook, 2021 & 2030
- 5.3 Global Lateral Flow Assay Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030
- 5.3.1 Clinical Testing
- 5.3.1.1 Clinical Testing Market, market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.3.1.2 Infectious Disease Testing
- 5.3.1.2.1 Infectious Disease Testing Market, market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.3.1.2.2 COVID-19 Testing
- 5.3.1.2.2.1 COVID-19 TESTING Market, market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.3.1.2.3 Mosquito-borne Disease Testing
- 5.3.1.2.3.1 Mosquito-borne Disease Testing Market, market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.3.1.2.4 Influenza Testing
- 5.3.1.2.4.1 Influenza Testing Market, market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.3.1.2.5 Sexually Transmitted Infection Testing
- 5.3.1.2.5.1 Sexually Transmitted Infection Testing Market, market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.3.1.2.5.2 HIV Testing
- 5.3.1.2.5.3 HIV Testing Market, market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.3.1.2.5.4 HPV Testing
- 5.3.1.2.5.5 HPV Testing Market, market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.3.1.2.5.6 Chlamydia Testing
- 5.3.1.2.5.7 Chlamydia Testing Market, market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.3.1.2.5.8 Syphilis Testing
- 5.3.1.2.5.9 Syphilis Testing Market, market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.3.1.2.5.10 Gonorrhea Testing
- 5.3.1.2.5.11 Gonorrhea Testing Market, market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.3.1.2.5.12 Other STI Testing
- 5.3.1.2.5.13 Other STI Testing Market, market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.3.1.2.6 Hepatitis Testing
- 5.3.1.2.6.1 Hepatitis Testing Market, market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.3.1.2.7 Tuberculosis Testing
- 5.3.1.2.7.1 Tuberculosis Testing Market, market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.3.1.2.8 Other Infectious Disease Testing
- 5.3.1.2.8.1 Other Infectious Disease Testing Market, market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.3.1.3 Cardiac Marker Testing
- 5.3.1.3.1 Cardiac Marker Testing Market, market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.3.1.3.2 Troponin I and T Testing
- 5.3.1.3.2.1 Troponin I and T Testing Market, market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.3.1.3.3 CK-MB Testing
- 5.3.1.3.3.1 CK-MB Testing Market, market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.3.1.3.4 BNP and NT-ProBNP Testing
- 5.3.1.3.4.1 BNP and NT-ProBNP Testing Market, market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.3.1.3.5 Myoglobin Testing
- 5.3.1.3.5.1 Myoglobin Testing Market, market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.3.1.3.6 D-Dimer Testing
- 5.3.1.3.6.1 D-Dimer Testing Market, market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.3.1.3.7 Other Cardiac Marker Tests
- 5.3.1.3.7.1 Other Cardiac Marker Tests Market, market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.3.1.4 Pregnancy & Fertility Testing
- 5.3.1.4.1 Pregnancy & Fertility Testing Market, market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.3.1.4.2 Pregnancy Testing
- 5.3.1.4.2.1 Pregnancy Testing Market, market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.3.1.4.3 Fertility Testing
- 5.3.1.4.3.1 Fertility Testing Market, market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.3.1.5 Cholesterol Testing/Lipid Profile Testing
- 5.3.1.5.1 Cholesterol Testing/Lipid Profile Testing Market, market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.3.1.6 Drugs of Abuse Testing
- 5.3.1.6.1 Drugs of Abuse Testing Market, market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.3.1.7 Other Clinical Tests
- 5.3.1.7.1 Other Clinical Tests Market, market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.3.2 Veterinary Diagnostics
- 5.3.2.1 Veterinary Diagnostics Market, Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 5.3.3 Food Safety & Environment Testing
- 5.3.3.1 Food Safety & Environment Testing Market, Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 5.3.4 Drug Development & Quality Testing
- 5.3.4.1 Drug Development & Quality Testing Market, market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 6 Lateral Flow Assay Market: Technique Estimates and Trend Analysis
- 6.1 Segment Dashboard
- 6.2 Lateral Flow Assay Market: Technique Outlook, 2021 & 2030
- 6.3 Global Lateral Flow Assay Market Size & Forecasts and Trend Analysis, by Technique, 2018 to 2030
- 6.4 Market Size & Forecasts And Trend Analyses, 2018 To 2030
- 6.4.1 Sandwich Assay
- 6.4.1.1 Sandwich Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.4.2 Competitive Assay
- 6.4.2.1 Competitive Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.4.3 Multiplex Detection Assay
- 6.4.3.1 Multiplex Detection Assay market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 7 Lateral Flow Assay Market: End-use Estimates and Trend Analysis
- 7.1 Segment Dashboard
- 7.2 Lateral Flow Assay Market: End-use Outlook, 2021 & 2030
- 7.3 Global Lateral Flow Assay Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030
- 7.3.1 Hospitals & Clinics
- 7.3.1.1 Hospitals & Clinics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.3.2 Diagnostic Laboratories
- 7.3.2.1 Diagnostic Laboratories Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.3.3 Home Care
- 7.3.3.1 Home Care Market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.3.4 Pharmaceutical & Biotechnology Companies
- 7.3.4.1 Pharmaceutical & Biotechnology Companies Market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.3.5 Other End Users
- 7.3.5.1 Other End Users Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 8 Lateral Flow Assay Market: Test Type Estimates and Trend Analysis
- 8.1 Segment Dashboard
- 8.2 Lateral Flow Assay Market: Test Type Outlook, 2021 & 2030
- 8.3 Global Lateral Flow Assay Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030
- 8.3.1 Lateral Flow Immunoassay
- 8.3.1.1 Lateral Flow Immunoassay Market, Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.3.2 Nucleic Acid Lateral Flow Assay
- 8.3.2.1 Nucleic Acid Lateral Flow Assay Market, Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 9 Lateral Flow Assay Market: Regional Estimates & Trend Analysis, by Product, Application, Technique, End Use, & Test Type
- 9.1 Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
- 9.2 Definitions & Scope
- 9.3 Lateral flow assay market: Regional outlook, 2021 & 2030
- 9.4 Regional Market Share, 2021
- 9.4.1 North America
- 9.4.2 Europe
- 9.4.3 Asia Pacific
- 9.4.4 Latin America
- 9.4.5 Middle East & Africa
- 9.5 Market Share Analysis by Region, 2021
- 9.5.1 North America Lateral Flow Assay Market Size & Forecasts and Trend Analysis, 2018 - 2030 (USD Million)
- 9.5.1.1 U.S.
- 9.5.1.1.1 U.S. Lateral Flow Assay Market, 2018 - 2030 (USD Million)
- 9.5.1.2 Canada
- 9.5.1.2.1 Canada Lateral Flow Assay Market, 2018 - 2030 (USD Million)
- 9.5.2 Europe Market Size & Forecasts And Trend Analysis, 2018 To 2030 (USD Million)
- 9.5.2.1 U.K.
- 9.5.2.1.1 U.K. Lateral Flow Assay Market, 2018 - 2030 (USD Million)
- 9.5.2.2 Germany
- 9.5.2.2.1 Germany Lateral Flow Assay Market, 2018 - 2030 (USD Million)
- 9.5.2.3 Spain
- 9.5.2.3.1 Spain Lateral Flow Assay Market, 2018 - 2030 (USD Million)
- 9.5.2.4 France
- 9.5.2.4.1 France Lateral Flow Assay Market, 2018 - 2030 (USD Million)
- 9.5.2.5 Italy
- 9.5.2.5.1 Italy Lateral Flow Assay Market, 2018 - 2030 (USD Million)
- 9.5.2.6 Russia
- 9.5.2.6.1 Russia Lateral Flow Assay Market, 2018 - 2030 (USD Million)
- 9.5.3 Asia Pacific Market Size & Forecasts And Trend Analysis, 2018 To 2030 (USD Million)
- 9.5.3.1 Japan
- 9.5.3.1.1 Japan Lateral Flow Assay Market, 2018 - 2030 (USD Million)
- 9.5.3.2 China
- 9.5.3.2.1 China Lateral Flow Assay Market, 2018 - 2030 (USD Million)
- 9.5.3.3 India
- 9.5.3.3.1 India Lateral Flow Assay Market, 2018 - 2030 (USD Million)
- 9.5.3.4 South Korea
- 9.5.3.4.1 South Korea Lateral Flow Assay Market, 2018 - 2030 (USD Million)
- 9.5.3.5 Singapore
- 9.5.3.5.1 Singapore Lateral Flow Assay Market, 2018 - 2030 (USD Million)
- 9.5.3.6 Australia
- 9.5.3.6.1 Australia Lateral Flow Assay Market, 2018 - 2030 (USD Million)
- 9.5.4 Latin America Market Size & Forecasts And Trend Analysis, 2018 To 2030 (USD Million)
- 9.5.4.1 Brazil
- 9.5.4.1.1 Brazil Lateral Flow Assay Market, 2018 - 2030 (USD Million)
- 9.5.4.2 Mexico
- 9.5.4.2.1 Mexico Lateral Flow Assay Market, 2018 - 2030 (USD Million)
- 9.5.4.3 Argentina
- 9.5.4.3.1 Argentina Lateral Flow Assay Market, 2018 - 2030 (USD Million)
- 9.5.5 Middle East & Africa Market Size & Forecasts And Trend Analysis, 2018 To 2030 (USD Million)
- 9.5.5.1 South Africa
- 9.5.5.1.1 South Africa Lateral Flow Assay Market, 2018 - 2030 (USD Million)
- 9.5.5.2 Saudi Arabia
- 9.5.5.2.1 Saudi Arabia Lateral Flow Assay Market, 2018 - 2030 (USD Million)
- 9.5.5.3 UAE
- 9.5.5.3.1 UAE Lateral Flow Assay Market, 2018 - 2030 (USD Million)
Chapter 10 Lateral Flow Assay Market Competitive Landscape
- 10.1 Recent Developments & Impact Analysis, by Key Market Participants
- 10.2 Strategy Framework
- 10.3 Company Categorization
- 10.4 Lateral Flow Assay Market, List of Major Market Players
- 10.5 Company Market Share, by Key Market Participants, 2021
- 10.6 Company Profiles
- 10.6.1 Abbott Laboratories
- 10.6.1.1 Company Overview
- 10.6.1.2 Financial Performance
- 10.6.1.3 Product Benchmarking
- 10.6.1.4 Strategic Initiatives
- 10.6.2 Thermo Fisher Scientific, Inc.
- 10.6.2.1 Company Overview
- 10.6.2.2 Financial Performance
- 10.6.2.3 Product Benchmarking
- 10.6.2.4 Strategic Initiatives
- 10.6.3 F. Hoffmann-La Roche AG
- 10.6.3.1 Company Overview
- 10.6.3.2 Financial Performance
- 10.6.3.3 Product Benchmarking
- 10.6.3.4 Strategic Initiatives
- 10.6.4 Bio-Rad Laboratories, Inc.
- 10.6.4.1 Company Overview
- 10.6.4.2 Financial Performance
- 10.6.4.3 Product Benchmarking
- 10.6.4.4 Strategic Initiatives
- 10.6.5 bioMerieux SA
- 10.6.5.1 Company Overview
- 10.6.5.2 Financial Performance
- 10.6.5.3 Product Benchmarking
- 10.6.5.4 Strategic Initiatives
- 10.6.6 Quidel Corporation
- 10.6.6.1 Company Overview
- 10.6.6.2 Financial Performance
- 10.6.6.3 Product Benchmarking
- 10.6.6.4 Strategic Initiatives
- 10.6.7 Hologic, Inc.
- 10.6.7.1 Company Overview
- 10.6.7.2 Financial Performance
- 10.6.7.3 Product Benchmarking
- 10.6.8 PerkinElmer, Inc.
- 10.6.8.1 Company Overview
- 10.6.8.2 Financial Performance
- 10.6.8.3 Product Benchmarking
- 10.6.8.4 Strategic Initiatives
- 10.6.9 Merck KGaA
- 10.6.9.1 Company Overview
- 10.6.9.1 Financial Performance
- 10.6.9.2 Product Benchmarking
- 10.6.9.3 Strategic Initiatives
- 10.6.10 BD
- 10.6.10.1 Company Overview
- 10.6.10.2 Financial Performance
- 10.6.10.3 Product Benchmarking
- 10.6.10.4 Strategic Initiatives
- 10.6.11 Siemens Healthineers
- 10.6.11.1 Company Overview
- 10.6.11.2 Financial Performance
- 10.6.11.3 Product Benchmarking
- 10.6.11.4 Strategic Initiatives
- 10.6.12 Danaher Corporation
- 10.6.12.1 Company Overview
- 10.6.12.2 Financial Performance
- 10.6.12.3 Product Benchmarking
- 10.6.12.4 Strategic Initiatives
- 10.6.13 QIAGEN N.V.
- 10.6.13.1 Company Overview
- 10.6.13.2 Financial Performance
- 10.6.13.3 Product Benchmarking
- 10.6.13.4 Strategic Initiatives
- 10.7 List of Lateral Flow Assay Instruments Market Players, by Region
- 10.8 List of Rapid Diagnostic Kits Market Service Providers, By Region
- 10.8.1 Clinical Laboratory Services